Helix BioMedix, Inc. (HXBM)
OTCMKTS · Delayed Price · Currency is USD
2.000
0.00 (0.00%)
At close: Dec 31, 2025
Helix BioMedix Revenue
Helix BioMedix had revenue of $469.07K in the quarter ending September 30, 2012, with 18.84% growth. This brings the company's revenue in the last twelve months to $2.07M, up 14.56% year-over-year. In the year 2011, Helix BioMedix had annual revenue of $1.89M with 122.07% growth.
Revenue (ttm)
2.07M
Revenue Growth
+14.56%
P/S Ratio
0.22
Revenue / Employee
258.24K
Employees
8
Market Cap
449.42K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2011 | 1.89M | 1.04M | 122.07% |
| Dec 31, 2010 | 851.68K | 460.42K | 117.67% |
| Dec 31, 2009 | 391.27K | -171.61K | -30.49% |
| Dec 31, 2008 | 562.88K | 98.94K | 21.33% |
| Dec 31, 2007 | 463.94K | 393.00K | 553.99% |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2002 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Regenerative Medical Technology Group | 5.04M |
| Hemagen Diagnostics | 4.04M |
| Scorpius Holdings | 2.41M |
| Regen BioPharma | 236.56K |
| CNBX Pharmaceuticals | 40.64K |
| THC Farmaceuticals | 18.52K |
| Oncology Pharma | 10.21K |